Health care investor Nate Sadeghi says Pfizer is holding back bad news on it's Alzheimer's drug., tells Human Genome to sell to Glaxo and likes Vertex and Gilead Sciences.
Health care investor Nate Sadeghi says Pfizer is holding back bad news on its Alzheimer's drug, tells Human Genome to sell to Glaxo and likes Vertex and Gilead Sciences.